Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats
出版年份 2020 全文链接
标题
Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats
作者
关键词
Tranilast, Doxorubicin, Angiotensin II, Chymase, Myocardial hypertrophy
出版物
LIFE SCIENCES
Volume 267, Issue -, Pages 118984
出版商
Elsevier BV
发表日期
2020-12-29
DOI
10.1016/j.lfs.2020.118984
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats
- (2020) Mohammad Sheibani et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Doxorubicin‑induced oxidative and nitrosative stress: Mitochondrial connexin 43 is at the crossroads
- (2020) Michela Pecoraro et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Salidroside Attenuates Doxorubicin-Induced Cardiac Dysfunction Partially Through Activation of QKI/FoxO1 Pathway
- (2020) Fangying Yan et al. Journal of Cardiovascular Translational Research
- Tranilast Directly Targets NLRP3 to Protect Melanocytes From Keratinocyte-Derived IL-1β Under Oxidative Stress
- (2020) Tongtian Zhuang et al. Frontiers in Cell and Developmental Biology
- MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1
- (2019) Xuerong Zhao et al. PHARMACOLOGICAL RESEARCH
- ST2/IL-33 signaling in cardiac fibrosis
- (2019) Elena Vianello et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Rotenone and 3-bromopyruvate toxicity impacts electrical and structural cardiac remodeling in rats
- (2019) Chengchuang Zhan et al. TOXICOLOGY LETTERS
- Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
- (2018) Kaviyarasi Renu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products
- (2018) Jie Yu et al. PHYTOMEDICINE
- Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010–2018)
- (2018) Sarfaraz Ahmad et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Prolonged QTc indicates the clinical severity and poor prognosis in patients with isolated left ventricular non-compaction
- (2017) Hongmei Zhou et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Role of connexin 43 in different forms of intercellular communication – gap junctions, extracellular vesicles and tunnelling nanotubes
- (2017) Teresa M. Ribeiro-Rodrigues et al. JOURNAL OF CELL SCIENCE
- LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy
- (2017) Yan Xia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- TGF-β1 Signaling and Tissue Fibrosis
- (2017) Kevin K. Kim et al. Cold Spring Harbor Perspectives in Biology
- Anti-Allergic Drugs Tranilast and Ketotifen Dose-Dependently Exert Mast Cell-Stabilizing Properties
- (2016) Asuka Baba et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Biological Basis for Cardiac Repair After Myocardial Infarction
- (2016) Sumanth D. Prabhu et al. CIRCULATION RESEARCH
- Cross-Talk between Human Mast Cells and Bronchial Epithelial Cells in Plasminogen Activator Inhibitor-1 Production via Transforming Growth Factor-β1
- (2015) Seong H. Cho et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Tranilast reduces serum IL-6 and IL-13 and protects against thioacetamide-induced acute liver injury and hepatic encephalopathy
- (2015) Rania R. Abdelaziz et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Tranilast: A review of its therapeutic applications
- (2015) Sara Darakhshan et al. PHARMACOLOGICAL RESEARCH
- Cardiotoxicity in rabbits after a low-level exposure to diazinon, propoxur, and chlorpyrifos
- (2014) A Zafiropoulos et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Protection against Ovariectomy-Induced Bone Loss by Tranilast
- (2014) Tien Van Phan et al. PLoS One
- The pathogenesis of cardiac fibrosis
- (2013) Ping Kong et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
- (2013) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
- (2013) Filipa S. Carvalho et al. MEDICINAL RESEARCH REVIEWS
- Short-term ACE inhibition confers long-term protection against target organ damage
- (2012) Taben M Hale et al. HYPERTENSION RESEARCH
- Tranilast Prevents Atrial Remodeling and Development of Atrial Fibrillation in a Canine Model of Atrial Tachycardia and Left Ventricular Dysfunction
- (2012) Yosuke Nakatani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Potential Therapeutic Targets for Cardiac Fibrosis
- (2010) Andrew Leask CIRCULATION RESEARCH
- Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy
- (2010) S. M. Tan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo
- (2009) Shao-hui Zhang et al. ACTA PHARMACOLOGICA SINICA
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but down-regulates the pro-inflammatory cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW264.7 macrophages
- (2008) Hyun-Ock Pae et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now